FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,733 | -83.1% | 21,572 | -62.1% | 0.00% | -100.0% |
| Q2 2023 | $270,648 | -17.6% | 56,859 | -1.3% | 0.00% | -33.3% |
| Q1 2023 | $328,304 | -73.1% | 57,597 | -52.4% | 0.00% | -72.7% |
| Q4 2022 | $1,220,053 | -57.2% | 120,917 | -5.0% | 0.01% | -57.7% |
| Q3 2022 | $2,851,000 | -17.8% | 127,218 | -9.1% | 0.03% | -3.7% |
| Q2 2022 | $3,468,000 | -32.4% | 139,974 | +5.7% | 0.03% | -12.9% |
| Q1 2022 | $5,132,000 | -44.1% | 132,375 | -15.6% | 0.03% | -35.4% |
| Q4 2021 | $9,179,000 | +10.9% | 156,888 | +12.3% | 0.05% | -4.0% |
| Q3 2021 | $8,278,000 | -8.4% | 139,663 | +34.1% | 0.05% | -5.7% |
| Q2 2021 | $9,041,000 | +3.5% | 104,174 | -1.7% | 0.05% | -7.0% |
| Q1 2021 | $8,734,000 | +3.9% | 105,930 | +14.6% | 0.06% | +7.5% |
| Q4 2020 | $8,403,000 | +260.5% | 92,408 | +58.5% | 0.05% | +211.8% |
| Q3 2020 | $2,331,000 | +16.0% | 58,308 | -0.4% | 0.02% | +6.2% |
| Q2 2020 | $2,009,000 | +167.2% | 58,558 | +72.9% | 0.02% | +100.0% |
| Q1 2020 | $752,000 | +92.3% | 33,868 | +69.6% | 0.01% | +166.7% |
| Q4 2019 | $391,000 | +98.5% | 19,965 | +57.8% | 0.00% | +50.0% |
| Q3 2019 | $197,000 | +358.1% | 12,653 | +19.0% | 0.00% | – |
| Q3 2017 | $43,000 | +30.3% | 10,636 | +3.3% | 0.00% | – |
| Q2 2017 | $33,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |